X0609 4 2026-03-16 0001036262 INTEST CORP INTT 0001918873 McManus Joseph Richard Jr. C/O INTEST CORP 804 EAST GATE DR, SUITE 200 MT. LAUREL NJ 08054 0 1 0 0 Division Pres-Electronic Test 0 Common Stock 2026-03-16 4 A 0 2535 0 A 33454 D Common Stock 2026-03-16 4 A 0 2535 0 A 35989 D Common Stock 2026-03-17 4 F 0 296 14.46 D 35693 D Employee Stock Option (right to buy) 14.47 2026-03-16 4 A 0 4284 0 A 2036-03-15 Common Stock 4284 4284 D Employee Stock Option (right to buy) 7.74 2035-03-16 Common Stock 2006 2006 D Employee Stock Option (right to buy) 7.74 2035-03-16 Common Stock 7954 7954 D Employee Stock Option (right to buy) 11.33 2034-03-05 Common Stock 5600 5600 D Employee Stock Option (right to buy) 16.06 2033-03-07 Common Stock 3576 3576 D Employee Stock Option (right to buy) 8.14 2032-04-27 Common Stock 13880 13880 D Employee Stock Option (right to buy) 13.13 2031-04-27 Common Stock 10000 10000 D These restricted shares were granted pursuant to the InTest Corporation 2023 Stock Incentive Plan (the "Plan") in a transaction exempt under Rule 16b-3 and will vest in four equal annual installments commencing on March 16, 2027. These performance-based restricted shares were granted pursuant to the Plan in a transaction exempt under Rule 16b-3 and will vest in March 2029 dependent upon certain performance criteria. The amount shown reflects the number of shares that will vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 3,803 These shares were withheld to cover tax withholding obligations on the vesting of restricted stock on March 17, 2026. This option was granted pursuant to the Plan in a transaction exempt under Rule 16b-3 and will vest in four equal annual installments commencing on March 16, 2027. This option vests in four equal annual installments commencing on March 17, 2026. This option vests in four equal annual installments commencing on March 6, 2025. This option vests in four equal annual installments commencing on March 8, 2024. This option vests in four equal annual installments commencing on April 28, 2023. This option is fully vested as of the date of this report. /s/ Duncan Gilmour, Attorney-in-Fact for Joseph McManus 2026-03-18